Zobrazeno 1 - 10
of 137
pro vyhledávání: '"psoriasis/drug therapy"'
Publikováno v:
Acta Médica Portuguesa, Vol 32, Iss 3, Pp 214-218 (2019)
Introduction: Ustekinumab is a monoclonal antibody directed against the p40 subunit common to both IL-12 and IL-23 cytokines. Although the evidence of ustekinumab efficacy and safety in clinical trials is extensively recognized, data on its use in cl
Externí odkaz:
https://doaj.org/article/82c5c712cb1a4d908dfc43ee5d091385
Autor:
Ying-Ying Leung, Tatiana V. Korotaeva, Liliana Candia, Susanne Juhl Pedersen, Wilson Bautista Molano, Eric M. Ruderman, Radjesh Bisoendial, Rodolfo Perez-Alamino, Wendy Olsder, Burkhard Möller, Simeon Grazio, Tania Gudu, Girish M. Mody, Carlos Pineda, Helena Raffayova, Sherry Rohekar, Claudia Goldenstein-Schainberg, Sergio R. Gutierrez Urena, Julio César Casasola Vargas, Bhowmik Meghnathi, Roopa Prasad, Pascal Richette, Jose Roberto S. Miranda, Nikolas Malliotis, Ulla Lindqvist, David Simon, Amara Ezeonyeji, Enrique R. Soriano, Oliver FitzGerald
Publikováno v:
Journal of Rheumatology, 50(1), 119-130. Journal of Rheumatology
Leung, Ying-Ying; Korotaeva, Tatiana V; Candia, Liliana; Pedersen, Susanne Juhl; Bautista Molano, Wilson; Ruderman, Eric M; Bisoendia, Radjesh; Perez-Alamino, Rodolfo; Olsder, Wendy; Möller, B; Grazio, Simeon; Gudu, Tania; Mody, Girish M; Pineda, Carlos; Raffayova, Helena; Rohekar, Sherry; Goldenstein-Schainberg, Claudia; Gutierrez Urena, Sergio R; Casasola Vargas, Julio César; Meghnathi, Bhowmik; ... (2023). Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The journal of rheumatology, 50(1), pp. 119-130. The Journal of Rheumatology Publishing Company Limited 10.3899/jrheum.220315
Leung, Ying-Ying; Korotaeva, Tatiana V; Candia, Liliana; Pedersen, Susanne Juhl; Bautista Molano, Wilson; Ruderman, Eric M; Bisoendia, Radjesh; Perez-Alamino, Rodolfo; Olsder, Wendy; Möller, B; Grazio, Simeon; Gudu, Tania; Mody, Girish M; Pineda, Carlos; Raffayova, Helena; Rohekar, Sherry; Goldenstein-Schainberg, Claudia; Gutierrez Urena, Sergio R; Casasola Vargas, Julio César; Meghnathi, Bhowmik; ... (2023). Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The journal of rheumatology, 50(1), pp. 119-130. The Journal of Rheumatology Publishing Company Limited 10.3899/jrheum.220315
ObjectiveWe aimed to compile evidence for the efficacy and safety of therapeutic options for the peripheral arthritis domain of psoriatic arthritis (PsA) for the revised 2021 Group in Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAP
Publikováno v:
Elgaard, C D B, Iversen, L & Hjuler, K F 2023, ' Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis ', Drugs in R&D, vol. 23, no. 2, pp. 155–163 . https://doi.org/10.1007/s40268-023-00422-w
BACKGROUND: Clinical trials have established the efficacy of brodalumab in treatment of psoriasis and psoriatic arthritis. Real-world evidence is needed to fully evaluate the drug.OBJECTIVE: Here we investigate drug survival and clinical effectivenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c450f0e85a196986fbf8f4782ee1b2b
https://pure.au.dk/portal/da/publications/singlecentre-realworld-study-on-drug-survival-and-effectiveness-of-brodalumab-for-treatment-of-psoriasis-and-psoriatic-arthritis(9c38be6f-9124-4535-8491-d06e451958fe).html
https://pure.au.dk/portal/da/publications/singlecentre-realworld-study-on-drug-survival-and-effectiveness-of-brodalumab-for-treatment-of-psoriasis-and-psoriatic-arthritis(9c38be6f-9124-4535-8491-d06e451958fe).html
Autor:
Ben Abdallah, Hakim, Seeler, Sabine, Bregnhøj, Anne, Ghatnekar, Gautam, Kristensen, Lasse S, Iversen, Lars, Johansen, Claus
Publikováno v:
Ben Abdallah, H, Seeler, S, Bregnhøj, A, Ghatnekar, G, Kristensen, L S, Iversen, L & Johansen, C 2023, ' Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation ', Frontiers in Immunology, vol. 14, pp. 1128897 . https://doi.org/10.3389/fimmu.2023.1128897
IntroductionChronic inflammatory skin diseases may have a profound negative impact on the quality of life. Current treatment options may be inadequate, offering an unsatisfactory response or side effects. Therefore, ongoing efforts exist to identify
Autor:
Petra Cetkovská, Iva Dediol, Marija Šola, Martina Kojanová, Katarina Trčko, Antoanela Čarija, Romana Čeović, Daniela Ledić-Drvar, Marija Kaštelan, Andina Hrabar, Myriam Cordey Missoup, Khalid Mamun
Publikováno v:
Advances in Therapy
Volume 40
Issue 4
Volume 40
Issue 4
Introduction: The broad and sustained efficacy of apremilast for psoriasis has been demonstrated in randomized and real-world observational studies. Data from Central and Eastern Europe (CEE) are lacking. Moreover, apremilast use in this region is li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5857410ebff20d07be2edafe611fce
https://doi.org/10.1007/s12325-023-02468-3
https://doi.org/10.1007/s12325-023-02468-3
Autor:
Lars Iversen, Curdin Conrad, Liv Eidsmo, Antonio Costanzo, Joanna Narbutt, Andreas Pinter, Külli Kingo, Raquel Rivera Diaz, Frank Kolbinger, ManikPrabhu Nanna, Jennifer Annika Frueh, Piotr Jagiello
Publikováno v:
Iversen, L, Conrad, C, Eidsmo, L, Costanzo, A, Narbutt, J, Pinter, A, Kingo, K, Rivera diaz, R, Kolbinger, F, Nanna, M, Frueh, J A & Jagiello, P 2023, ' Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients : Week 52 results from the STEPIn study ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 5, pp. 1004-1016 . https://doi.org/10.1111/jdv.18846
Iversen, L, Conrad, C, Eidsmo, L, Costanzo, A, Narbutt, J, Pinter, A, Kingo, K, Rivera Diaz, R, Kolbinger, F, Nanna, M, Frueh, J A & Jagiello, P 2023, ' Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients : Week 52 results from the STEPIn study ', Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 37, no. 5, pp. 1004-1016 . https://doi.org/10.1111/jdv.18846
Iversen, L, Conrad, C, Eidsmo, L, Costanzo, A, Narbutt, J, Pinter, A, Kingo, K, Rivera Diaz, R, Kolbinger, F, Nanna, M, Frueh, J A & Jagiello, P 2023, ' Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients : Week 52 results from the STEPIn study ', Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 37, no. 5, pp. 1004-1016 . https://doi.org/10.1111/jdv.18846
Background: Biologic treatments have been studied mainly in patients with a long-term history of psoriasis and previous treatment failures. Objectives: The purpose of this primary analysis of the STEPIn study is to determine whether early interventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a2c0a4e81aeb5fccdb5e0a136ac5f12
https://curis.ku.dk/ws/files/356899332/Acad_Dermatol_Venereol_2023_Iversen_Secukinumab_demonstrates_superiority_over_narrow_band_ultraviolet_B_phototherapy.pdf
https://curis.ku.dk/ws/files/356899332/Acad_Dermatol_Venereol_2023_Iversen_Secukinumab_demonstrates_superiority_over_narrow_band_ultraviolet_B_phototherapy.pdf
Autor:
Tiago Torres, Paulo Filipe
Publikováno v:
Revista da Sociedade Portuguesa de Dermatologia e Venereologia, Vol 76, Iss 1 (2018)
Psoriasis is a chronic, inflammatory, immune-mediated, potentially disfiguring and disabling skin disorder, affecting over 100 million individuals worldwide. Calcipotriol plus betamethasone fixed-combination (0.005% Cal/0.064% BD) is the recommended
Externí odkaz:
https://doaj.org/article/f154e48dbca54cca99883581d5947504
Autor:
Mia-Louise Nielsen, Troels Christian Petersen, Julia-Tatjana Maul, Jashin J. Wu, Mads Kirchheiner Rasmussen, Trine Bertelsen, Kawa Khaled Ajgeiy, Lone Skov, Simon Francis Thomsen, Jacob P. Thyssen, Alexander Egeberg
Publikováno v:
Nielsen, M-L, Petersen, T C, Maul, J-T, Wu, J J, Rasmussen, M K, Bertelsen, T, Ajgeiy, K K, Skov, L, Thomsen, S F, Thyssen, J P & Egeberg, A 2022, ' Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level ', JAMA Dermatology, vol. 158, no. 10, pp. 1149-1156 . https://doi.org/10.1001/jamadermatol.2022.3171
ImportanceIdentifying the optimal long-term biologic therapy for patients with psoriasis is often done through trial and error.ObjectiveTo identify the optimal biologic therapy for individual patients with psoriasis using predictive statistical and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d5eab4dcf6828b0894557d417ce2bcf
https://pure.au.dk/portal/da/publications/multivariable-predictive-models-to-identify-the-optimal-biologic-therapy-for-treatment-of-patients-with-psoriasis-at-the-individual-level(66fecd37-919e-491a-ae3b-7c48572bad2c).html
https://pure.au.dk/portal/da/publications/multivariable-predictive-models-to-identify-the-optimal-biologic-therapy-for-treatment-of-patients-with-psoriasis-at-the-individual-level(66fecd37-919e-491a-ae3b-7c48572bad2c).html
Autor:
Sabine Seeler, Liviu-Ionut Moldovan, Trine Bertelsen, Henrik Hager, Lars Iversen, Claus Johansen, Jørgen Kjems, Lasse Sommer Kristensen
Publikováno v:
Seeler, S, Moldovan, L-I, Bertelsen, T, Hager, H, Iversen, L, Johansen, C, Kjems, J & Sommer Kristensen, L 2022, ' Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatment ', PLOS ONE, vol. 17, no. 9, e0275219 . https://doi.org/10.1371/journal.pone.0275219
Psoriasis is a common chronic inflammatory skin disease accompanied by heterogenous clinical and histological features, including a characteristic keratinocyte hyperproliferation and dermal immunogenic profile. In addition, psoriasis is associated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1692e52c3082dd63dc9b39957511cf
https://pure.au.dk/portal/da/publications/global-circrna-expression-changes-predate-clinical-and-histological-improvements-of-psoriasis-patients-upon-secukinumab-treatment(bf7303da-e8ff-4926-96d1-94b2a1ac3744).html
https://pure.au.dk/portal/da/publications/global-circrna-expression-changes-predate-clinical-and-histological-improvements-of-psoriasis-patients-upon-secukinumab-treatment(bf7303da-e8ff-4926-96d1-94b2a1ac3744).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.